Mitchell E. Reff
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Growth Hormone and Insulin-like Growth Factors, Chronic Lymphocytic Leukemia Research, T-cell and B-cell Immunology
Most-Cited Works
- → Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII(2001)324 cited
- → Elimination of Fc Receptor-Dependent Effector Functions of a Modified IgG4 Monoclonal Antibody to Human CD4(2000)131 cited
- → Targeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer Therapy(2006)116 cited
- → Enhanced cell culture performance using inducible anti‐apoptotic genes E1B‐19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells(2006)102 cited
- → “Primatization” of Recombinant Antibodies for Immunotherapy of Human Diseases: A Macaque/Human Chimeric Antibody Against Human CD4(1992)86 cited
- → Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects(2005)86 cited
- → Future of Monoclonal Antibodies in the Treatment of Hematologic Malignancies(2002)80 cited
- → A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity(2011)79 cited
- → Differential Effects of Polyadenylation Regions on Gene Expression in Mammalian Cells(1986)74 cited
- → Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response(2010)68 cited